Interview: Ahmed Zaghloul – President, Egypt Otsuka
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Egypt Otsuka was established in 10th of Ramadan City in 1992 aiming to supply Otsuka’s pharmaceutical products in the Egyptian market and succeeded to the business of Arab Otsuka Pharmaceutical Co., S.A.E. established in the Public Free Zone (special tax free zone for export) in Cairo in 1977. Since then, Egypt Otsuka has been engaged in manufacturing and distributing intravenous infusions and therapeutic drugs in Egypt and neighbouring countries in the Middle East as well as in Africa. Along with growing demands for intravenous infusion products in those markets, Egypt Otsuka’s production capacity has nearly reached a maximum level and its expansion has been an immediate task to meet the growing demand.
In June of 2014, acquired 80% of Ateco Pharma Egypt, an Egyptian intravenous infusion manufacturing company and has a large domestic market share. This acquisition enabled Egypt Otsuka to expand its annual production capacity of intravenous infusions by approximately 50% in volume and sufficiently meet the increasing demands in the market. Ateco Pharma Egypt was renamed as “Otsuka Ateco Pharma Egypt” following the acquisition.
Contact
ar El-Sadik St, off Dr. Abdallah El-Araby street (Tayaran), Nasr City, 11759 Cairo
Phone: 20 201 536 9561
Fax: 20 201 536 9564
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Concerted efforts are, at last, being made to redraw the rulebook and tidy up a local regulatory landscape long renowned for its torpor, dysfunction and ineffectuality. The Egyptian pharmaceutical market…
In an exclusive discussion with Focus Reports, Egyptian Minister of Health, Dr. Ahmed El Din Rady sets out his blueprint for improving the nation’s welfare and securing positive public health…
Ten years after his first interview with Focus Reports, Wafik Bardissi discusses Minapharm’s position as the leading biosimilar manufacturer in the Middle East. Has Egypt taken steps to incentivize the development or registration…
Fresenius Kabi’s general manager for the MENA region discusses evolving attitudes towards clinical nutrition for critically ill patients and Egypt’s positioning as a knowledge center and source of medical professionals…
Former Egyptian Minister of Health Adel Adawy discusses the reforms needed in the Egyptian healthcare system and the progress made in the fight against HCV over the last two years.…
Japanese company Otsuka envisioned Egypt as a hub for its Middle East and African operations as early as 1995. The president of the local subsidiary discusses the current activities of…
Oncology already represents the second largest portion of Egypt’s public healthcare budget, and despite limited public funding, demand for and acceptance of innovation is high, according to Roche’s regional general…
While growth forecasts for the MENA region remain high, falling oil prices and political instability are creating significant government budgetary challenges for the industry to adapt to. Janssen’s area managing…
“My primary concern is not the current economic situation, but rather the fact that there does not appear to be a clear vision for how Egypt can overcome these challenges…
The founder of the Middle East’s largest pharmaceutical company, EIPICO, discusses the evolution of the Egyptian pharmaceutical industry over the last 50 years, and his hopes for the industry over…
Eva Pharma is one of the fastest growing pharmaceutical companies in the MENA region, and CEO Riad Armanious is aiming to take the company from the 21st ranked generic company…
After choosing Egypt as the first country to host a production plant in the Middle East, AstraZeneca is interested in strengthening its foothold in the market. The country president discusses…
See our Cookie Privacy Policy Here
